Prevention of foreign body reaction in a pre-clinical large animal model

Journal of Controlled Release

Volumn 202, Issue , 2015, Pages 101-107

  Kastellorizios, Michail ^a   Papadimitrakopoulos, Fotios ^a   Burgess, Diane J ^a  

^a UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

Animal models; Biocompatibility; Biosensor; Control drug delivery; Foreign body response; PLGA microsphere

Indexed keywords

ANIMALS; BIOCOMPATIBILITY; BIOMEDICAL EQUIPMENT; BIOSENSORS; COPOLYMERS; DRUG DELIVERY; IMPLANTS (SURGICAL); MICROSPHERES; NEURAL PROSTHESES; PATHOLOGY; RATS;

ANIMAL MODEL; COMPOSITE FORMULATIONS; FOREIGN BODY REACTIONS; FOREIGN BODY RESPONSE; PLGA MICROSPHERES; POLY(LACTICCO-GLYCOLIC ACID) MICROSPHERE; PRE-CLINICAL TESTING; SUBCUTANEOUS IMPLANTS;

COMPOSITE COATINGS;

COLLAGEN; DEXAMETHASONE; MICROSPHERE; POLYGLACTIN; POLYVINYL ALCOHOL; SILICON; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYVINYL ALCOHOL HYDROGEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG COATING; DRUG FORMULATION; DRUG RELEASE; EXPERIMENTAL PIG; EXPERIMENTAL RAT; FEMALE; FOREIGN BODY REACTION; GOTTINGEN MINIPIG; HYDROGEL; IMPLANT; IMPLANTATION; MOLECULAR WEIGHT; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; SKIN FIBROSIS; SPECIES COMPARISON; TISSUE REACTION; ANIMAL; CHEMISTRY; FOREIGN-BODY REACTION; MINIPIG; PIG; PROSTHESES AND ORTHOSES;

ANIMALS; DEXAMETHASONE; FEMALE; FOREIGN-BODY REACTION; LACTIC ACID; MICROSPHERES; MODELS, ANIMAL; POLYGLYCOLIC ACID; POLYVINYL ALCOHOL; PROSTHESES AND IMPLANTS; RATS; SWINE; SWINE, MINIATURE;

EID: 84922534433     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2015.01.038     Document Type: Article

References (51)

1. J.M. Morais, F. Papadimitrakopoulos, and D.J. Burgess Biomaterials/tissue interactions: possible solutions to overcome foreign body response AAPS J. 12 2010 188 196
2. Ward W. Kenneth A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis J. Diab. Sci. Technol. 2 2008 768 777
3. A. Thiele, U. Bilkenroth, M. Bloching, and S. Knipping Foreign body reaction to materials implanted as biocompatible for internal fixation HNO 56 2008 545 548
4. S.A. Wallace, and K.L. Brown Foreign body reaction to sutures and other materials Texas State J. Med. 44 1948 463 466
5. K.F. Swingle, and F.E. Shideman Phases of the inflammatory response to subcutaneous implantation of a cotton pellet and their modification by certain anti-inflammatory agents J. Pharmacol. Exp. Ther. 183 1972 226 234
6. L.D. Ferrell, R. Lee, C. Brixko, N.M. Bass, J.R. Lake, and J.P. Roberts Hepatic granulomas following liver transplantation. Clinicopathologic features in 42 patients Transplantation 60 1995 926 933
7. Y. Kinoshita, M. Kirigakubo, M. Kobayashi, T. Tabata, K. Shimura, and Y. Ikada Study on the efficacy of biodegradable poly(L-lactide) mesh for supporting transplanted particulate cancellous bone and marrow: experiment involving subcutaneous implantation in dogs Biomaterials 14 1993 729 736
8. C.C. Congdon Bone marrow transplantation Science 171 1971 1116 1124
9. Y. Wang, F. Papadimitrakopoulos, and D.J. Burgess Polymeric "smart" coatings to prevent foreign body response to implantable biosensors J. Control. Release 169 2013 341 347
10. U. Bhardwaj, F. Papadimitrakopoulos, and D.J. Burgess A review of the development of a vehicle for localized and controlled drug delivery for implantable biosensors J. Diab. Sci. Technol. 2 2008 1016 1029
11. U. Bhardwaj, R. Sura, F. Papadimitrakopoulos, and D.J. Burgess Controlling acute inflammation with fast releasing dexamethasone-PLGA microsphere/pva hydrogel composites for implantable devices J. Diab. Sci. Technol. 1 2007 8 17
12. S. Vaddiraju, D.J. Burgess, I. Tomazos, F.C. Jain, and F. Papadimitrakopoulos Technologies for continuous glucose monitoring: current problems and future promises J. Diab. Sci. Technol. 4 2010 1540 1562
13. P.A. Lips, M.J. van Luyn, F. Chiellini, L.A. Brouwer, I.W. Velthoen, and P.J. Dijkstra Biocompatibility and degradation of aliphatic segmented poly(ester amide)s: in vitro and in vivo evaluation J. Biomed. Mater. Res. A 76 2006 699 710
14. Y. Liu, X. Zheng Shu, and G.D. Prestwich Biocompatibility and stability of disulfide-crosslinked hyaluronan films Biomaterials 26 2005 4737 4746
15. B.J. Pol, P.B. van Wachem, M.J. van Luyn, L. van der Does, and A. Bantjes In vivo testing of crosslinked polyethers. I. Tissue reactions and biodegradation J. Biomed. Mater. Res. 32 1996 307 320
16. H. Zhang, C. Bian, J.K. Jackson, F. Khademolhosseini, H.M. Burt, and M. Chiao Fabrication of robust hydrogel coatings on polydimethylsiloxane substrates using micropillar anchor structures with chemical surface modification ACS Appl. Mater. Interfaces 6 2014 9126 9133
17. P. Lin, C.W. Lin, R. Mansour, and F. Gu Improving biocompatibility by surface modification techniques on implantable bioelectronics Biosens. Bioelectron. 47 2013 451 460
18. Y. Li, C.M. Liu, J.Y. Yang, Y.H. Gao, X.S. Li, and G.H. Que Anti-biofouling properties of amphiphilic phosphorylcholine polymer films Colloids Surf. B: Biointerfaces 85 2011 125 130
19. A.J. Scardino, H. Zhang, D.J. Cookson, R.N. Lamb, and R. de Nys The role of nano-roughness in antifouling Biofouling 25 2009 757 767
20. M. Dahlstrom, P.R. Jonsson, J. Lausmaa, T. Arnebrant, M. Sjogren, and K. Holmberg Impact of polymer surface affinity of novel antifouling agents Biotechnol. Bioeng. 86 2004 1 8
21. I.V. Maiborodin, I.V. Kuznetsova, E.A. Beregovoi, A.I. Shevela, M.I. Barannik, and V.I. Maiborodina Reaction of rat tissues to implantation of lactic acid-based biodegradable polymer Bull. Exp. Biol. Med. 156 2014 874 879
22. I.V. Kuznetsova, I.V. Maiborodin, A.I. Shevela, M.I. Barannik, A.A. Manaev, and A.I. Brombin Local tissue reaction to implantation of biodegradable suture materials Bull. Exp. Biol. Med. 157 2014 390 394
23. K.A. Hernandez, R.C. Hooper, T. Boyko, A.R. Golas, M. van Harten, and D.Q. Wu Reduction of suture associated inflammation after 28 days using novel biocompatible pseudoprotein poly(ester amide) biomaterials J. Biomed. Mater. Res. B Appl. Biomater. 1032 2014 457 463
24. S. Ronkko, K. Kaarniranta, G. Kalesnykas, and H. Uusitalo Biocompatibility of different poly(lactide-coglycolide) polymers implanted into the subconjunctival space in rats Ophthalmic Res. 46 2011 55 65
25. R.N. Khurana, S.N. Appa, C.A. McCannel, M.J. Elman, S.E. Wittenberg, and D.J. Parks Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies Ophthalmology 121 2014 67 71
26. X. Liu, I. De Scheerder, and W. Desmet Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis Expert. Rev. Cardiovasc. Ther. 2 2004 653 660
27. T. Hickey, D. Kreutzer, D.J. Burgess, and F. Moussy Dexamethasone/PLGA microspheres for continuous delivery of an anti-inflammatory drug for implantable medical devices Biomaterials 23 2002 1649 1656
28. T. Hickey, D. Kreutzer, D.J. Burgess, and F. Moussy In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices J. Biomed. Mater. Res. 61 2002 180 187
29. J. Frucht-Pery, C.S. Siganos, A. Solomon, T. Shvartzenberg, C. Richard, and C. Trinquand Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study Am J. Ophthalmol. 127 1999 148 152
30. A.S. Radovsky, and J.F. Van Vleet Effects of dexamethasone elution on tissue reaction around stimulating electrodes of endocardial pacing leads in dogs Am. Heart J. 117 1989 1288 1298
31. A.R. Rosenthal, B. Appleton, R. Zimmerman, and J.L. Hopkins Intraocular copper foreign bodies. Use of dexamethasone to suppress inflammation Arch. Ophthalmol. 94 1976 1571 1576
32. T. Sasabe Studies on experimental pathology using dexamethasone with reference to its influence on the living body Zasshi Tokyo Ika Daigaku 25 1967 937 974
33. P. Khatri, S. Roedder, N. Kimura, K. De Vusser, A.A. Morgan, and Y. Gong A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation J. Exp. Med. 210 2013 2205 2221
34. T. Okamoto, S. Okamoto, Y. Fujimoto, Y. Tabata, and S. Uemoto Suppression of acute rejection by administration of prostaglandin E2 receptor subtype 4 agonist in rat organ transplantation models J. Surg. Res. 183 2013 852 859
35. H. Zhang, L. Chen, G. Gu, Z. Guo, F. Gong, and S. Wu Clinical observation and nursing care on the prevention of abdominal organ cluster transplantation rejection J. Clin. Nurs. 22 2013 1599 1603
36. L.G. Alvarado The problem of rejection in organ transplants Rev. Bras. Med. 26 1969 427 428
37. J.L. Corman, N. Kashiwagi, K.A. Porter, G. Andres, S. Iwatsuki, and C.W. Putnam Unsuccessful attempts to control hyperacute rejection of human renal homografts with F(ab') 2 and citrate organ pretreatment Transplantation 16 1973 60 63
38. R.G. Dalton Rejection: the major problem of organ transplantation in man and animals Vet. Rec. 94 1974 333 336
39. F. Stella, D. Alfani, C. Stella, S. Battistelli, R. Troccoli, and R. Cortesini Differential diagnosis of rejection and cyclosporin nephrotoxicity in organ transplantation using exfoliative urinary cytology Quad. Sclavo Diagn. Clin. Lab. 21 1985 330 340
40. R. Venkataramanan, R.J. Ptachcinski, G.J. Burckart, S. Yang, and T.E. Starzl Extraction ratio of cyclosporine in a liver transplant patient with organ rejection J. Pharm. Sci. 74 1985 901 902
41. J.F. Bach Renewal of organ transplantation: towards the control of rejection Rev. Prat. 36 1986 1615 1619
42. S.D. Patil, F. Papadimitrakopoulos, and D.J. Burgess Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control Diabetes Technol. Ther. 6 2004 887 897
43. S.D. Patil, F. Papadmitrakopoulos, and D.J. Burgess Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis J. Control. Release 117 2007 68 79
44. B.S. Zolnik, and D.J. Burgess Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres J. Control. Release 127 2008 137 145
45. U. Bhardwaj, R. Sura, F. Papadimitrakopoulos, and D.J. Burgess PLGA/PVA hydrogel composites for long-term inflammation control following s.c. implantation Int. J. Pharm. 384 2010 78 86
46. Y. Wang, S. Vaddiraju, L. Qiang, X. Xu, F. Papadimitrakopoulos, and D.J. Burgess Effect of dexamethasone-loaded poly(lactic-co-glycolic acid) microsphere/poly(vinyl alcohol) hydrogel composite coatings on the basic characteristics of implantable glucose sensors J. Diab. Sci. Technol. 6 2012 1445 1453
47. I.H. Ploemen, H.J. Hirschberg, H. Kraan, A. Zeltner, S. van Kuijk, and D.P. Lankveld Minipigs as an animal model for dermal vaccine delivery Comp. Med. 64 2014 50 54
48. M.K. Dame, D.M. Spahlinger, M. DaSilva, P. Perone, R. Dunstan, and J. Varani Establishment and characteristics of Gottingen minipig skin in organ culture and monolayer cell culture: relevance to drug safety testing In vitro Cell. Dev. Biol. Anim. 44 2008 245 252
49. J.A. Mahl, B.E. Vogel, M. Court, M. Kolopp, D. Roman, and V. Nogues The minipig in dermatotoxicology: methods and challenges Exp. Toxicol. Pathol. 57 2006 341 345
50. Z. Dincer, S. Jones, and R. Haworth Preclinical safety assessment of a DNA vaccine using particle-mediated epidermal delivery in domestic pig, minipig and mouse Exp. Toxicol. Pathol. 57 2006 351 357
51. J. Shen, and D.J. Burgess Accelerated in vitro release testing of implantable PLGA microsphere/PVA hydrogel composite coatings Int. J. Pharm. 422 2012 341 348